Tower Research Capital LLC (Trc) A Tyr Pharma Inc Call Options Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LIFE
# of Institutions
79Shares Held
39.5MCall Options Held
38.8KPut Options Held
27.3K-
Federated Hermes, Inc. Pittsburgh, PA14.7MShares$27.3 Million0.06% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.88MShares$9.08 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.6MShares$6.71 Million0.0% of portfolio
-
Tikvah Management LLC Charlotte, NC2.46MShares$4.58 Million1.33% of portfolio
-
Woodline Partners LP San Francisco, CA1.68MShares$3.13 Million0.02% of portfolio
About aTYR PHARMA INC
- Ticker LIFE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,625,000
- Market Cap $53.2M
- Description
- aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...